Develops liver and intestinal toxicology tests for pharmaceutical companies.
Jun 2026Revenue $112K/yrExpenses $11.4M/yr
No trendCash runway ≈ 2 months from Jun 2026
Figures by year
When will VivoSim Labs be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $112K and expenses $11.4M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Mar 2026 | $131K | $11.6M | −$11.5M |
| Mar 2025 | $144K | $12.8M | −$12.6M |
| Mar 2024 | $109K | $15.2M | −$15.1M |
| Mar 2023 | $370K | $18.1M | −$17.7M |
| Mar 2022 | $1.50M | $13.0M | −$11.5M |
| Mar 2021 | $0.00 | $16.8M | −$16.8M |
| Mar 2020 | $2.20M | $23.7M | −$21.5M |
| Mar 2019 | $3.09M | $30.4M | −$27.3M |
| Mar 2018 | $4.60M | $39.9M | −$35.3M |
| Mar 2017 | $4.23M | $42.8M | −$38.6M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.